Today we sit down with Dr. Ivan Kairatov, a veteran biopharma expert whose work at the intersection of medicinal chemistry and computational biology is pushing the boundaries of treatment for central nervous system disorders. For decades, the neurokinin-1 receptor, or NK1R, was a tantalizing but
In the digital age of medicine, clinicians are paradoxically drowning in an ocean of patient data while simultaneously thirsting for clear, actionable insights at the point of care. The emergence of AI-Powered Chart Review represents a significant advancement in the healthcare technology sector,
The daunting reality for thousands of individuals is that a diagnosis of end-stage liver failure begins a desperate race against time, a wait for a life-saving organ that, for many, will never arrive. This critical shortage of donor organs has created a persistent crisis in modern medicine, with
We are joined today by Ivan Kairatov, a biopharma expert with deep insights into the technological innovations shaping the future of medicine. We will be exploring the recent expansion of a groundbreaking protein discovery platform into Asia, discussing its installation at two leading Taiwanese
The world can fade to black not with a sudden closure of the eyes, but through a slow, imperceptible narrowing of one's peripheral vision that often goes unnoticed until it is far too late. This insidious process is the hallmark of glaucoma, a leading cause of irreversible blindness that affects
A comprehensive systematic review and meta-analysis led by researchers at the Icahn School of Medicine at Mount Sinai has established a significant association between exposure to per- and polyfluoroalkyl substances and an increased risk of gestational diabetes mellitus, alongside altered markers
